How is the Neumora Therapeutics Inc. today?

The Neumora Therapeutics Inc. today is trading in the green, up by 1.27% at 0.80.

How has Neumora Therapeutics Inc. performed historically?

The Neumora Therapeutics Inc. is currently trading up 1.27% on an intraday basis in the past week the index rose 11.11%. The index has been down -43.26% in the past quarter and fell -92.00% in the past year. You can view this in the overview section.

What is Neumora Therapeutics Inc. Annual Net Profit?

Neumora Therapeutics Inc. Annual Net Profit fell 3.33% in the last year to $243.79 M. Its sector's average net profit growth for the last fiscal year was -13.86%.

What is Neumora Therapeutics Inc. Price to Earning Ratio?

Neumora Therapeutics Inc. Price to Earning Ratio is -0.5, which is negative.

What is Neumora Therapeutics Inc. Stock Price?

Neumora Therapeutics Inc. Stock Price fell 92% and underperformed its sector by 119.28% in the past year.

What is Neumora Therapeutics Inc. Quarterly Net profit?

Neumora Therapeutics Inc. Quarterly Net profit fell 26.57% YoY to $67.99 M. Its sector's average net profit growth YoY for the quarter was -238.4%.

What is Neumora Therapeutics Inc. Debt to Equity Ratio?

Neumora Therapeutics Inc. Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Neumora Therapeutics Inc. Return on Equity(ROE)?

Neumora Therapeutics Inc. Return on Equity(ROE) for the last financial year was -64.48%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Neumora Therapeutics Inc. Mutual Fund Holding?

Neumora Therapeutics Inc. Mutual Fund Holding decreased by 3.6% in the last quarter to 13.34.

What is Neumora Therapeutics Inc. Institutional Holding?

Neumora Therapeutics Inc. Institutional Holding decreased by 10.39% in the last quarter to 39.19.

Neumora Therapeutics Inc. XNAS: NMRA

Neumora Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Neumora Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Neumora Therapeutics Inc.
Rating: 0.97175
Author: Trendlyne DVM scores

about

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pip...

0.80 0.01 (1.27%)

95.35% Fall from 52W High

116.2K XNAS Volume

XNAS 05 Jun, 2025 9:58 AM (EDT)

Board Meeting

The next board meeting for Neumora Therapeutics Inc. is on 13 Jun 2025 for the purpose of Neumora Therapeutics Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

14.0 / 100

Technically Bearish

24.9 / 100

No estimates available

Neumora Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Neumora Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pip...

95.35% Fall from 52W High

SWOT Analysis

Neumora Therapeutics Inc. Live Price Chart

Neumora Therapeutics Inc. FAQ

How is Neumora Therapeutics Inc. today?

Neumora Therapeutics Inc. today is trading in the green, and is up by 1.27% at 0.80.

How has Neumora Therapeutics Inc. performed historically?

Neumora Therapeutics Inc. is currently trading up 1.27% on an intraday basis. In the past week the stock rose 11.11%. stock has been down -43.26% in the past quarter and fell -92.00% in the past year. You can view this in the overview section.